InfuSystem outlines 6% to 8% revenue growth for 2026 following contract restructuring
Source: SeekingAlpha
2026-02-24 11:28:34 ET
More on InfuSystem
- InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
- InfuSystem: Regulatory Backed Market Catalyst
- InfuSystem reports mixed Q4 results; introduces FY26 outlook
- Seeking Alpha’s Quant Rating on InfuSystem
- Historical earnings data for InfuSystem
Read the full article on Seeking Alpha
For further details see:
InfuSystem outlines 6% to 8% revenue growth for 2026 following contract restructuring
InfuSystems Holdings Inc.
NASDAQ: INFU
INFU Trading
2.71% G/L:
$9.86 Last:
48,004 Volume:
$9.69 Open:
INFU Latest News
February 24, 2026 06:30:00 am
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
February 17, 2026 06:30:00 am
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
December 10, 2025 05:37:00 pm
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
November 10, 2025 04:30:00 pm
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
INFU Stock Data
$154,046,586
18,017,858
0.09%
30
N/A
Medical Equipment & Supplies
Healthcare
US
Rochester Hills
